Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.

[1]  A. Fishman,et al.  Amrinone and exercise performance in patients with chronic heart failure. , 1981, The American journal of cardiology.

[2]  J S Janicki,et al.  Contractile mechanics and interaction of the right and left ventricles. , 1981, The American journal of cardiology.

[3]  N. Reichek,et al.  Long-term vasodilator therapy with trimazosin in chronic cardiac failure. , 1980, The New England journal of medicine.

[4]  J. Halperin,et al.  Central and Peripheral Hemodynamic Effects of Angiotensin Inhibition in Patients with Refractory Congestive Heart Failure , 1980, Circulation.

[5]  G. E. Newman,et al.  Rest and Exercise Hemodynamic Effects of Oral Hydralazine in Patients with Coronary Artery Disease and Left Ventricular Dysfunction , 1980, Circulation.

[6]  R. Gorlin,et al.  Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.

[7]  B. Brundage,et al.  Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure. , 1979, The American journal of cardiology.

[8]  G. Y. Lesher,et al.  Cardiotonic Activity of Amrinone–Win 40680 [5‐Amino‐3,4f‐bipyridin‐6(lH)‐one] , 1979, Circulation research.

[9]  J. S. Janicki,et al.  The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations. , 1979, The American journal of cardiology.

[10]  J S Janicki,et al.  The heart as a muscle--pump system and the concept of heart failure. , 1979, American heart journal.

[11]  D. Fitchett,et al.  Hydralazine in the management of left ventricular failure. , 1979, The American journal of cardiology.

[12]  D. Mason,et al.  Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure. , 1979, The American journal of cardiology.

[13]  E. Sonnenblick,et al.  Amrinone A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man , 1979, Circulation.

[14]  E. Braunwald,et al.  Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.

[15]  C. Bush,et al.  The Cardiovascular Effects of the Continuous Infusion of Dobutamine in Patients with Severe Cardiac Failure , 1977, Circulation.

[16]  J. Cohn,et al.  Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.

[17]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[18]  J. Cohn,et al.  Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. , 1977, Annals of internal medicine.

[19]  B. Massie,et al.  Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.

[20]  J. Longhurst,et al.  A Comparison of Regional Blood Flow and Oxygen Utilization During Dynamic Forearm Exercise in Normal Subjects and Patients with Congestive Heart Failure , 1974, Circulation.

[21]  J. Naughton,et al.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. , 1972, The American journal of cardiology.

[22]  E. Braunwald,et al.  A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. , 1968, The Journal of clinical investigation.

[23]  E. Braunwald,et al.  Characterization of the Circulatory Response to Maximal Upright Exercise in Normal Subjects and Patients with Heart Disease , 1967, Circulation.

[24]  J. Ross,et al.  Left Ventricular Performance During Muscular Exercise in Patients with and without Cardiac Dysfunction , 1966, Circulation.

[25]  A. Fishman,et al.  The congested lung. , 1959, Journal of chronic diseases.

[26]  K. Donald,et al.  A study of minute to minute changes of arterio-venous oxygen content difference, oxygen uptake and cardiac output and rate of achievement of a steady state during exercise in rheumatic heart disease. , 1954, The Journal of clinical investigation.

[27]  P. Wood.  Diseases of the Heart and Circulation , 1902, The Hospital.

[28]  A. Liedtke,et al.  Cardiocirculatory dynamics in the normal and failing heart. , 1981, Annual review of physiology.

[29]  W. Parmley,et al.  The role of vasodilator therapy in heart failure. , 1977, Progress in cardiovascular diseases.